<?xml version='1.0' encoding='utf-8'?>
<document id="30192434"><sentence text="Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes." /><sentence text="Cytochrome P450 (CYP) 2D6 metabolizes a wide range of xenobiotics and is characterized by a huge interindividual variability" /><sentence text=" A recent clinical study highlighted differential magnitude of CYP inhibition as a function of CYP2D6 genotype" /><sentence text=" The aim of this study was to investigate the effect of CYP2D6 genotype on the inhibition of dextromethorphan O-demethylation by duloxetine and paroxetine in human liver microsomes (HLMs)"><entity charOffset="93-109" id="DDI-PubMed.30192434.s4.e0" text="dextromethorphan" /><entity charOffset="129-139" id="DDI-PubMed.30192434.s4.e1" text="duloxetine" /><entity charOffset="144-154" id="DDI-PubMed.30192434.s4.e2" text="paroxetine" /><pair ddi="false" e1="DDI-PubMed.30192434.s4.e0" e2="DDI-PubMed.30192434.s4.e0" /><pair ddi="false" e1="DDI-PubMed.30192434.s4.e0" e2="DDI-PubMed.30192434.s4.e1" /><pair ddi="false" e1="DDI-PubMed.30192434.s4.e0" e2="DDI-PubMed.30192434.s4.e2" /><pair ddi="false" e1="DDI-PubMed.30192434.s4.e1" e2="DDI-PubMed.30192434.s4.e1" /><pair ddi="false" e1="DDI-PubMed.30192434.s4.e1" e2="DDI-PubMed.30192434.s4.e2" /></sentence><sentence text=" The study focused on genotypes defined by the combination of two fully functional alleles (activity score 2, AS 2, n = 6), of one fully functional and one reduced allele (activity score 1" /><sentence text="5, AS 1" /><sentence text="5, n = 4) and of one fully functional and one non-functional allele (activity score 1, AS 1, n = 6), which all predict extensive metabolizer phenotype" /><sentence text=" Kinetic experiments showed that maximal reaction velocity was affected by CYP2D6 genotype, with a decrease in 33% of Vmax in AS 1 HLMs compared to AS 2 (P = 0" /><sentence text="06)" /><sentence text=" No difference in inhibition parameters Ki , KI and kinact was observed neither with the competitive inhibitor duloxetine nor with the time-dependent inhibitor paroxetine"><entity charOffset="111-121" id="DDI-PubMed.30192434.s10.e0" text="duloxetine" /><entity charOffset="160-170" id="DDI-PubMed.30192434.s10.e1" text="paroxetine" /><pair ddi="false" e1="DDI-PubMed.30192434.s10.e0" e2="DDI-PubMed.30192434.s10.e0" /><pair ddi="false" e1="DDI-PubMed.30192434.s10.e0" e2="DDI-PubMed.30192434.s10.e1" /></sentence><sentence text=" Among the genotypes tested, we found no difference in absolute CYP2D6 microsomal levels with ELISA immunoquantification" /><sentence text=" Therefore, our results suggest that genotype-sensitive magnitude of drug-drug interactions recently observed in vivo is likely to be due to differential amounts of functional enzymes at the microsomal level rather than to a difference in inhibition potencies across genotypes, which motivates for further quantitative proteomic investigations of functional and variant CYP2D6 alleles" /><sentence text="" /></document>